QSS
ARCT icon

Quantitative Systematic Strategies’s Arcturus Therapeutics ARCT Stock Holding History

Quantitative Systematic Strategies’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,004
Closed -$211K – 424
2015
Q4 		$211K Sell
5,004
-4,084
-45% -$184K 0.06% 828
2015
Q3 		$384K Buy
+9,088
New +$478K 0.19% 232

Other funds holding ARCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Quantitative Systematic Strategies's ARCT Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of Arcturus Therapeutics (ARCT) in Q1 2016, closing a stake of 5,004 shares — an estimated $211K sold.

Quantitative Systematic Strategies first reported a position in ARCT in Q3 2015 and held it in 2 quarters. The position peaked at $384K in Q3 2015. 46 funds tracked by Wall St. Rank hold ARCT as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining Arcturus Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 5,004 Arcturus Therapeutics shares in Q1 2016, an estimated $211K.
  • Quantitative Systematic Strategies first reported a position in Arcturus Therapeutics in Q3 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Arcturus Therapeutics position peaked at $384K in Q3 2015.
  • 46 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.